Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.60
+0.23 (1.86%)
At close: May 22, 2026, 4:00 PM EDT
12.58
-0.02 (-0.16%)
Pre-market: May 26, 2026, 4:38 AM EDT
Intellia Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Sell Maintains $8 | Sell | Maintains | $8 | -36.51% | May 14, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 | Hold | Maintains | $15 | +19.05% | May 13, 2026 |
| Bernstein | Bernstein | Hold Reiterates $13 → $17 | Hold | Reiterates | $13 → $17 | +34.92% | May 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $30 → $25 | Buy | Reiterates | $30 → $25 | +98.41% | May 13, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $15 | Hold | Maintains | $15 | +19.05% | May 13, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $20 → $19 | Hold | Maintains | $20 → $19 | +50.79% | May 12, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Hold Maintains $12 | Hold | Maintains | $12 | -4.76% | May 12, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $9 | Sell | Maintains | $9 | -28.57% | May 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.